PetMed Express grants 49,923 shares to director

PetMed Express director Tamar Elkeles received a 49,923-share restricted stock grant vesting in 2027 as part of equity compensation.

Rhea-AI Filing Summary

PETMED EXPRESS INC (symbol: PETS) is the issuer of record for a Form 4 filing submitted to the SEC. Elkeles Tamar reported acquisition or exercise transactions in this Form 4 filing.

PETMED EXPRESS INC (PETS) reported that director Tamar Elkeles received a grant of 49,923 shares of Common Stock on September 17, 2026. The award is a restricted stock award under the PetMed Express, Inc. 2024 Omnibus Incentive Plan, granted at $0.00 per share and held as direct ownership. The restricted shares vest in full on September 17, 2027, subject to Dr. Elkeles’ continued service on the Board of Directors. No transactions were made under a Rule 10b5-1 trading plan.

Insider Trade Summary

Grant/Award: 49,923 shares

Grant/Award 1 txn

Insider Elkeles Tamar

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	49,923	$0.00	$0.00

Holdings After Transaction: Common Stock — 49,923 shares (Direct)

Footnotes (1)

1. F1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan which will vest in its entirety on September 17, 2027, subject to continued service on the Board of Directors.

Key Figures

Restricted shares granted: 49,923 shares Grant price per share: $0.00 per share Shares owned after transaction: 49,923 shares +2 more

5 metrics

Restricted shares granted 49,923 shares Restricted stock award to director Tamar Elkeles on September 17, 2026

Grant price per share $0.00 per share Equity compensation restricted stock award under 2024 Omnibus Incentive Plan

Shares owned after transaction 49,923 shares Total direct holdings of PetMed Express Common Stock by Tamar Elkeles after the award

Transaction date September 17, 2026 Grant date of restricted stock award to director Tamar Elkeles

Vesting date September 17, 2027 Date when the restricted stock award vests in full, subject to continued Board service

Key Terms

restricted stock award, 2024 Omnibus Incentive Plan, continued service on the Board of Directors

3 terms

restricted stock award financial

"Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

2024 Omnibus Incentive Plan financial

"made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan which will vest"

continued service on the Board of Directors financial

"will vest in its entirety on September 17, 2027, subject to continued service on the Board of Directors"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PETS report for director Tamar Elkeles?

PETS reported that director Tamar Elkeles received a restricted stock award of 49,923 Common Stock shares on September 17, 2026, under the PetMed Express, Inc. 2024 Omnibus Incentive Plan at $0.00 per share, as equity compensation.

How many PETS shares does Tamar Elkeles hold after this Form 4 transaction?

After the reported award, Tamar Elkeles holds 49,923 shares of PetMed Express Common Stock in direct ownership, all of which are from this restricted stock grant.

When do the restricted PETS shares granted to Tamar Elkeles vest?

The 49,923-share restricted stock award granted to Tamar Elkeles will vest in its entirety on September 17, 2027, provided she continues her service on the Board of Directors through that date.

What plan governs the restricted stock award reported by PETS?

The award to Tamar Elkeles was granted under the PetMed Express, Inc. 2024 Omnibus Incentive Plan as a restricted stock award that vests in full after one year of continued Board service from the grant date.

Was Tamar Elkeles’s PETS stock award made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, and there is no footnote stating the award was made pursuant to a Rule 10b5-1 or similar pre-arranged trading plan.

Did Tamar Elkeles buy or sell PETS shares for cash in this Form 4?

No. The Form 4 reports a grant of 49,923 restricted shares at $0.00 per share, classified as a grant or award acquisition, with no open-market purchase or sale for cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/21/2026 - 08:59 AM Accepted by SEC EDGAR 09/21/2026 - 08:58 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elkeles Tamar

(Last) (First) (Middle)

C/O PETMED EXPRESS, INC.

420 SOUTH CONGRESS AVENUE

(Street)

DELRAY BEACH FLORIDA 33445

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PETMED EXPRESS INC [ PETS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2026		A		49,923(1)	A	$0	49,923	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan which will vest in its entirety on September 17, 2027, subject to continued service on the Board of Directors.

Remarks:

	/s/ Tamar Elkeles	09/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)